Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Ensysce Biosciences Inc
ENSC
Alternate Symbol(s):
ENSCW
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology...
, the Multi-Pill Abuse Resistant (MPAR) platform. Its lead product, PF614, is a TAAP extended-release oxycodone and a potential analgesic to treat severe pain. Its second product, PF614-MPAR, is to treat severe pain with the added benefit of oral overdose protection, is a combination product of the TAAP prodrug PF614 with a trypsin inhibitor. Additionally, nafamostat, which is an ingredient in its overdose protection combination products, is also being developed for the intended purpose of treating infection and pulmonary lung diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ENSC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(113)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 05, 2022 1:43pm
ENSC ....broke intra-day support at $2.21
I'd sat the Maggot will be taking this lower...keep your powder dry Cheers !
(113)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 05, 2022 12:00pm
ENSC .... Weakness is evident ; )
Heads up
(113)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 05, 2022 10:29am
ENSC..small position started ~$2.30.....will add on weakness
Cheers !
(113)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 05, 2022 8:22am
ENSC....early a.m runner with a NR ...
She gonna rip ; )
(51)
•••
TimSanders
X
Post by
TimSanders
on Sep 21, 2022 12:50pm
Whats the outstanding share count here?
(2)
•••
GeneralWolfe
X
Post by
GeneralWolfe
on May 06, 2022 11:11am
Get in while you can...
dirt cheap right now
(13075)
•••
SusanBolland
X
Comment by
SusanBolland
on Mar 29, 2022 5:58am
RE:ENSC ..... halted & resume
(113)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 18, 2022 2:49pm
ENSC ..... halted & resume
On watch
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Canadian clean tech company pioneering the upcycling of used motor oil into high value Group III base oils
A Canadian mineral company at the crossroads of electrification and defense
New Analyst Report Lifts Almonty Target Price to CDN$5.50